- Sort by:
- Browse by:
- Free
- audio + slides
- All slides included
Panel Discussion
Richard Pazdur
U.S. Food and Drug Administration, Silver Spring, MD, United States
Marc Theoret
U.S. Food and Drug Administration, Silver Spring, MD, United States
Israel Lowy
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States
Alan B. Sandler
Genentech, South San Francisco, CA, United States
Hesham A. Abdullah
AstraZeneca Pharmaceuticals LP, Rockville, MD, United States
Scot W. Ebbinghaus
Merck Research Laboratories - Rahway, North Wales, PA, United States
Kevin Chin
EMD Serono, Billerica, MA, United States
Fouad Namouni
Bristol-Myers Squibb Co., Lawrenceville, NJ, United States
- Free
- slides video
- audio + slides
- All slides included
Key questions for ctDNA analysis
Paul T Spellman
Oregon Health Science Univ., Portland, OR, United States
- Free
- slides video
- audio + slides
- All slides included
Title to be announced
Jamie Platt
Inivata, Research Triangle Park, NC, United States
- Free
- slides video
- audio + slides
- All slides included
The dual roles of analytical and clinical data in ctDNA test validation
Justin Odegaard
Guardant Health Inc., Redwood City, CA, United States
- Free
- audio + slides
- Some slides withheld
Analytical validation of liquid biopsy assays: current challenges and opportunities
Mark Sausen
Personal Genome Diagnostics, Baltimore, MD, United States
- Free
- slides video
- audio + slides
- All slides included
Introduction
Richard M. Marais
Cancer Research UK Manchester Inst., Manchester, United Kingdom
- Free
- audio + slides
- All slides included
Invited Speaker
John S Haurum
Cambridge, United Kingdom
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Susan M. Galbraith
AstraZeneca, Cambridge, United Kingdom
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Joanne M. Hackett
Genomics England, London, United Kingdom
- Free
- slides video
- audio + slides
- All slides included
Wrap-up
C. Simone Fishburn
BioCentury, Inc., Redwood City, CA, United States
- Free
- audio + slides
- All slides included
Panel Discussion
C. Simone Fishburn
BioCentury, Inc., Redwood City, CA, United States
Richard M. Marais
Cancer Research UK Manchester Inst., Manchester, United Kingdom
John S Haurum
Cambridge, United Kingdom
Susan M. Galbraith
AstraZeneca, Cambridge, United Kingdom
Joanne M. Hackett
Genomics England, London, United Kingdom
- Free
- audio only
- Audio only
Chairperson
George J Weiner
Univ. of Iowa Holden Comp. Cancer Ctr., Iowa City, IA, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
William Foster
Independent Advocate, Gary, IN, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Andreana Natalie Holowatyj
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Brittany A. Avin
Johns Hopkins Univ. School of Medicine, Baltimore, MD, United States
- Free
- slides video
- audio + slides
- All slides included
Immune-based therapies: Predictors of benefit
Mario Sznol
Yale Cancer Ctr., New Haven, CT, United States
- Free
- audio + slides
- Some slides withheld
Genomic profiling-identifying drivers
Funda Meric-Bernstam
UT MD Anderson Cancer Ctr., Houston, TX, United States
- Free
- slides video
- audio + slides
- All slides included
Companion and complementary diagnostics to inform drug development and approval
Gideon Blumenthal
U.S. Food and Drug Administration, Silver Spring, MD, United States
- Free
- audio + slides
- Some slides withheld
Practicing precision medicine: One patient at a time
Shivaani Kummar
Stanford University School of Medicine, Palo Alto, CA, United States
- Free
- slides video
- audio + slides
- All slides included
Introduction
Joshua L. Berlin
Biocentury, Redwood City, CA, United States
- Permission not
granted for presentation
Invited Speaker
Dan Zhang
Foundation Medical Development Ltd., Beijing, China
- Free
- audio only
- Audio only
Invited Speaker
Frank Jiang
CStone Pharmaceuticals, Shanghai, China
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Joan Shen
I-Mab Biopharma, Shanghai, China
- Free
- audio + slides
- All slides included
Panel Discussion
Joshua L. Berlin
BioCentury, Inc., Redwood City, CA, United States
Dan Zhang
Foundation Medical Development Ltd., Beijing, China
Frank Jiang
CStone Pharmaceuticals, Shanghai, China
Joan Shen
I-Mab Biopharma, Shanghai, China
- Free
- slides video
- audio + slides
- All slides included
CBER, Microbiome, and CAR-T in Solid Tumors
Ke Liu
U.S. Food and Drug Administration, Silver Spring, MD, United States